Introduction {#Sec1}
============

It is estimated that more than 1500 active pharmaceutical ingredients (APIs) are currently in use. Following use, these compounds can be emitted into the natural environment e.g. via wastewater collection and treatment networks (Boxall et al. [@CR12]; Ginebreda et al. [@CR32]). The ongoing use of many of these APIs by society means that the active substances and their major metabolites will occur in the environment continuously (Monteiro and Boxall [@CR60]).

For most pharmaceuticals in use, the evidence that they have deleterious effects on the natural environment is still limited and our knowledge of the fate of these pharmaceuticals in the environment is still deficient (Roos et al. [@CR65]). This is partly due to the fact that the number of APIs in use is large and that experimental data on the environmental levels, fate and effects are available for only a small proportion of these substances. For example, the knowledge of environmental exposure to antibiotics which may lead to possible evolution and dissemination of antibiotic-resistant pathogens in bacteria is limited (Bengtsson-Palme and Larsson [@CR8]). To experimentally assess the environmental risk of all APIs in use would be a challenge (Perazzolo et al. [@CR63]). One solution is to use formalized prioritization procedures that identify those substances in use that pose the greatest risks towards the natural environment (Boxall et al. [@CR12]). By using these approaches, experimental testing resources can then be focused on those substances that are likely to have the greatest impact.

Several studies have been recently performed that employ different approaches for ranking and assessing the risk posed by APIs to the environment. Most have focused on surface or drinking water and the risks to aquatic organisms or human health. These approaches have been applied in Switzerland (Perazzolo et al. [@CR63]), USA (Kostich and Lazorchak [@CR49]; Dong et al. [@CR19]), France (Besse and Garric [@CR9]), the UK (Boxall et al. [@CR13]; Guo et al. [@CR35]), South Korea (Kim et al. [@CR47]) and Sweden (Roos et al. [@CR65]). Many of these approaches use exposure and toxicological predictions so they can be readily applied to large numbers of compounds with limited data (Boxall et al. [@CR12]).

Most prioritization studies have focused on North America and Western Europe, so our knowledge of priorities in other geographical areas such as Eastern Europe, Africa, Asia and South America is limited. This can be partly explained by the challenges in obtaining information on API usage in these regions. Moreover, although there are strong incentives to introduce the evaluation of an antibiotic to select for resistance into environmental risk assessment guidelines (Bengtsson-Palme and Larsson [@CR8]), none of the previous prioritization approaches has attempted to assess the risk of antibiotics in the environment in terms of their potential to select for antimicrobial resistance.

In Iraq, there are no specific management guidelines for pharmaceuticals in the environment. Pharmaceuticals are freely available to everyone without any restriction and regulation or even without prescription, and there are many routes by which these substances are distributed to the population. One route is the public health sector which is represented by the Ministry of Health (MOH) via the state company for importation and distribution of drug and medical appliances (KIMADIA). The second source is the private sector (licensed and unlicensed low value manufacturers) which includes 23 manufacturing plants, importers and dispensers who supply the local markets with unknown quantities of pharmaceuticals. Additionally, all the locally produced and imported finished pharmaceuticals are not subjected to taxes in order to make them affordable for most of the population (USAID; [@CR73]; EMRO WHO [@CR58]; MOH [@CR57]).

With a highly urbanized population, Iraq still has insufficient environmental management and suffers from poor and old water distribution systems and contaminated main water resources (UNEP [@CR72]). Due to the absence of water quality regulations and the continuous discharges from industry and households via insufficient wastewater treatment plants (WWTPs), up to 19 % of the Iraqi population is exposed to unsafe water (UNEP [@CR72]; USAID [@CR73]). In addition, only 32 % of the population is served with wastewater treatment, meaning that a significant amount of untreated wastewater is released to the environment (COSIT [@CR33]). Few studies to evaluate the quality of environmental systems in Iraq have been performed, and most that have been performed have focused on monitoring the occurrence of trace metals, polycyclic aromatic hydrocarbons (PAHs) and non-polar lipids in the aquatic environment (Abaychi and DouAbul [@CR1]; Al-Saad [@CR4]; Rushdi et al. [@CR66]). The risks of emerging contaminants such as pharmaceuticals have been neglected.

The aim of the present study was therefore to establish the importance of API exposure as a pressure on the natural environment in Iraq and to identify APIs of most concern in local aquatic and terrestrial environments of the three main cities in the country (Baghdad, Mosul and Basrah), where only little is currently known about the exposure and effects of these substances. The prioritization approaches used to achieve this were based on the potential for APIs to enter the aquatic and terrestrial environments and their potential toxic effects on the ecosystems, bacterial community and human health.

Materials and methods {#Sec2}
=====================

Prioritization approach {#Sec3}
-----------------------

The prioritization approach is illustrated in Fig. [1](#Fig1){ref-type="fig"} and involved the use of predicted environmental concentrations (PECs) and concentrations relating to different effect endpoints (i.e. predicted no-effect concentrations (PNECs), human plasma therapeutic concentrations (H~T~PCs), minimal inhibitory concentrations (MICs) and minimal selective concentrations (MSCs)) for each of the pharmaceuticals in aquatic and terrestrial systems. PECs and PNECs were then used to calculate risk characterization ratios (RCRs) for apical endpoints, secondary poisoning, toxicity to humans and antimicrobial resistance selection. Pharmaceuticals were then ranked based on their RCRs where compounds with the highest RCRs were considered the highest priority.Fig. 1The developments of prioritization approach of pharmaceuticals in the environment in Iraq. *RCR* risk characterization ratios, *PECsw*, *PNECsw* predicted environmental concentration and predicted no-effect concentration in surface water, *PECsludge* predicted environmental concentration in sludge compartment, *PECsed*, *PNECsed* predicted environmental concentration and predicted no-effect concentration in sediment compartment, *WWTP*wastewater treatment plant, *BCF* fish bioconcentration factor, *BMF* biomagnification factor, *PECbiota* predicted environmental concentration in biota (e.g. fish), *PNEChuman* predicted no-effect concentration in humans from drinking water and fishery products consumption, *PECsoil* predicted environmental concentration in soil, *FSSPC* fish steady state plasma concentration, *H* ~*T*~ *PC* human therapeutic plasma concentration, *PECwarthworm* predicted environmental concentration in earthworm, *PNECearthworm* predicted no-effect concentration in earthworm, *PNECmammal* predicted no effect concentration in mammal, *MIC* minimal inhibitory concentration, *PNECresistance* predicted no-effect concentration for antibiotics resistance selection, *MSC* minimal selective concentration

Data collection {#Sec4}
---------------

### Usage data {#Sec5}

Data on the consumption of pharmaceuticals for hospitals and primary care centres in Iraq in 2014 were obtained from the state company KIMADIA (Kimadia, access 2014). To obtain the total amount of pharmaceuticals consumed, concentrations of active ingredient in packaging units (i.e. blister, bottle, etc.) were converted into mass units. Vitamins, medical supplements, electrolytes and vaccines were excluded which reduced the list of APIs to 99 compounds. In the case of combined medicines, only individual active ingredients were considered and summed up to calculate the weight of pharmaceutical compound.

Information is scarce on the use of over-the-counter pharmaceuticals in Iraq. However, research by the Center of Market Research and Consumer Protection at the University of Baghdad (Mohammed et al. [@CR59]) indicates that over-the-counter usage can contribute 68 % of the total usage of pharmaceuticals in Iraq. Therefore, to obtain a total pharmaceutical usage in Iraq (for both hospitals and primary care centres and over the counter), the results of the analysis of the KIMADIA data were multiplied by a factor of 3.125. Some APIs, such as cancer treatments or those used in surgical procedures in hospitals, were not corrected (multiplied by the factor) as they would not be distributed over the counter. The final usage data are provided in the supporting information (Table [S1](#MOESM1){ref-type="media"}).

### Effects data and physico-chemical properties {#Sec6}

To estimate the environmental risk posed by the pharmaceuticals to aquatic and terrestrial ecosystems in Iraq, data on toxicity of the APIs to algae, daphnia, fish and earthworms was used. The data collection included acute and chronic ecotoxicity endpoints (typically the most sensitive LC/EC50 value). These data were obtained from the peer-reviewed literature, grey literature and available online databases (e.g. Swedish voluntary environmental classification of pharmaceuticals at [www.fass.se](http://www.fass.se/)). As experimental ecotoxicity data were not available for a large number of the pharmaceuticals, estimation tools, such as Quantitative Structure-Property Relationships (QSAR) used in the Organisation for Economic Co-operation and Development (OECD QSAR, [@CR61]) Toolbox and the Ecological Structure Activity Relationship ECOSAR (USEPI 4.1) software, were used to fill data gaps (Guo et al. [@CR35]). The database present in the QSAR Toolbox was used to identify experimental data for molecules deemed 'similar' to each of the individual pharmaceutical with no data. Then, within the software, a relationship was built to allow an estimation of the ecotoxicological endpoint for the query molecule. Regarding human and mammalian toxicity effects from oral exposure, endpoints such as acceptable daily intake (ADI) values and median lethal dose (LD50) for rat/mouse were used (Technical Guidance for Deriving Environmental Quality Standards EC 2011, Carvalho et al. [@CR15]; Guo et al. [@CR35]). The H~T~PCs available in peer-reviewed publications were used in the fish plasma model. Finally, for terrestrial toxicity, earthworm acute toxicity (14-day LC50 in mM kg^−1^ dry soil) was predicted using the QSAR available in ECOSAR for compounds with no experimentally determined earthworm ecotoxicity data. Due to the absence of experimentally determined effects of antibiotics in complex microbial communities, the theoretical MICs, MSCs and PNECs selective resistance calculated by Bengtsson-Palme and Larsson ([@CR8]) were used.

Physico-chemical properties required for predicting the fate and behavior of pharmaceuticals in the environment were collated from published articles and open resources. DrugBank, NCCOS ([@CR20]) was used to obtain acid dissociation constants (pKa), and the CODATA ([@CR18]) database was used to obtain octanol-water partition coefficients (Kow). As there was a lack of experimental data on organic carbon partition coefficient (Koc) for the APIs, for compounds where experimental Koc data were not available, we used the estimation model developed by Franco and Trapp ([@CR30]). Excretion profiles for pharmaceuticals were obtained from the peer-reviewed literature, databases or pharmaceutical safety data sheets (i.e. MEDSAFE, Pfizer).

### Wastewater generation and dilution factor {#Sec7}

Information on wastewater disposal for the main highly urbanized cities in Iraq (Baghdad, Mosul and Basrah) was collected. The daily generated wastewater discharges are 1.6 million m^3^/day in Baghdad, 0.5 million m^3^/day in Mosul and 0.331 million m^3^/day in Basrah (COSIT [@CR34]). These data were used to calculate the wastewater generated per inhabitant (Supporting Information, Equation [S1](#MOESM1){ref-type="media"}).

It is difficult to determine the dilution factor (DF) in countries with none or very scarce hydrological information like Iraq. For this purpose, we therefore used two dilution factors of 10 and 40 which had been estimated based on a national scale for Iraq by Keller et al. ([@CR46]). The percentage of wastewater treatment efficiency will also be important for the calculation of exposure concentrations in surface water so information was also collected on the percentage connectivity to wastewater treatment plants for the three cities. Data on the population, wastewater per capita, wastewater treatment percentage and dilution factors for the cities under study is provided in Table [S3](#MOESM1){ref-type="media"} in the supporting information.

Exposure assessment {#Sec8}
-------------------

Predicted environmental concentrations of APIs on the usage list were calculated in aquatic systems (surface water and sediment) and terrestrial systems according to the Guideline on the Environmental Risk Assessment of Medicinal Products for Human Use (EMEA [@CR24]) and the Technical Guidance Document on Risk Assessment part II (TGD [@CR23]) with some modifications to be fitted to the case of Iraq. In surface water, PECsw values for APIs were calculated using the following equation (Eq.[1](#Equ1){ref-type=""}):$$\documentclass[12pt]{minimal}
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                \begin{document}$$ \mathrm{PECsw}=\frac{\mathrm{Subinhab}\times \mathrm{Fexc}}{\mathrm{WasteWinhab}\times \mathrm{Dilution}}\times \left(1-\frac{\mathrm{Sludge}\ \mathrm{inhab}\times \mathrm{K}\mathrm{o}\mathrm{c}\times \mathrm{focsludge}}{\mathrm{WasteWinhab}+\left(\mathrm{Sludge}\ \mathrm{inhab}\times \mathrm{K}\mathrm{o}\mathrm{c}\times \mathrm{focsludge}\right)}\right) $$\end{document}$$where PEC~SW~ is the PEC of an API in surface water. Sub~inhab~ is the consumed amount of pharmaceuticals per inhabitant in Iraq per day (mg/inh/day) and was calculated based on annual pharmaceutical consumption (kg year^−1^) and using the population of Iraq (34.2 million), (Eq. [S2](#MOESM1){ref-type="media"}, Supporting Information); DF is the dilution factor of 10 and 40 and WW~inhab~ is the daily amount of wastewater per inhabitant in either Baghdad, Mosul or Basrah. F~exc~ is the fraction of parent ingredients excreted unchanged via human metabolism. Sludge~inhab~ \[kg/inh/day\] is the mass of waste sludge per inhabitant per day, which is 0.074 (EC [@CR22]); Koc is the organic carbon partitioning coefficient determined experimentally or estimated according to Franco and Trapp ([@CR30]) for ionisable chemicals using Kow and pKa; and foc~sludge~ is the fraction of sludge organic carbon and was assumed to be 0.326 (Struijs et al. [@CR70]).

The assumption of removal by adsorption was just used in the case of Baghdad because of the absence of wastewater treatment in both Mosul and Basrah. For Mosul, there are no wastewater treatment plants in the city while for Basrah the efficiency percentage of wastewater treatment in existing WWTPs is zero (COSIT [@CR34]).

For sediment, the standard algorithms in the TGDII ([@CR23]) was used to estimate concentrations of the APIs in terms of wet weight (ww) (PECsed_ww), and since the final PECsed was calculated in terms of dry weight, a conversion step was applied to determine PECsed on a dry weight basis (Carvalho et al. [@CR15]) (Eqs. [S2](#MOESM1){ref-type="media"} to [S5](#MOESM1){ref-type="media"} in Supporting Information).

For the calculation of the PECbiota, the following equation was used.$$\documentclass[12pt]{minimal}
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where BCF is the bioconcentration factor for biota (e.g. fish) which was retrieved when available or calculated according to Fick et al. ([@CR28]) (Eq. [S7](#MOESM1){ref-type="media"}, Supporting Information). Default biomagnification factor (BMF) values were retrieved from technical guidance document (EC [@CR22]).

Data on measured levels of pharmaceuticals in fish plasma following exposure via water are still scarce (Fick et al. [@CR28]). As an indicator of specific drugs' potential to cause adverse pharmacological effects at certain concentrations, the fish steady state plasma concentration (FSSPC) resulting from exposure via surface water was calculated (Eq. [S8](#MOESM1){ref-type="media"} in Supporting Information). Predictions were based on estimations of the partitioning of an API between the aqueous phase and arterial blood in the fish (Pblood/water) (Eqs. [S9](#MOESM1){ref-type="media"} and [S10](#MOESM1){ref-type="media"} in Supporting Information). This partition coefficient was initially estimated based on the log K~OW~ of the API, and this was subsequently combined with the PECsw to estimate the FSSPC.

PECsoil was calculated since a PECsludge had been calculated using algorithms described in the TGD ([@CR23]). To estimate the concentration of an API in earthworms (PECearthworm), the concentration in the earthworms on a wet weight basis (C earthworm) was calculated using an estimate of the concentration in porewater (Cporewater) from PECsoil by considering the partitioning behaviour of substances between the soil and aqueous phase (Eqs. [S11](#MOESM1){ref-type="media"} to [S13](#MOESM1){ref-type="media"} in Supporting Information). The BCF for earthworms was calculated according to the approach in the TGD ([@CR23]).

Hazard characterization {#Sec9}
-----------------------

In order to calculate PNECs for toxicity to surface water organisms, effects data were divided by a relevant assessment factor (AF), i.e. acute QSAR data =1000; acute experimental data =100; chronic QSAR data =100 and chronic experimental data =10, (TGD [@CR23]). In instances where more than one ecotoxicological value was found, the most sensitive endpoint was used for the generation of the PNEC. PNECs for earthworms were obtained by dividing the 14-day LC50 value by an AF of 1000. PNECs for mammals were obtained by dividing median lethal doses for mouse or rat by an AF of 100. PNECs for resistance were obtained from MSCs using an AF of 10. AFs were not used for the estimation of concentrations causing mode of action-based effects (using the H~T~PC) or for the MICs for microbes. Specific equations are provided in the Supporting Information (Eqs. [S9--S11](#MOESM1){ref-type="media"}).

Results and discussion {#Sec10}
======================

Experimental data availability {#Sec11}
------------------------------

Experimental acute ecotoxicological data were only available for 51 of the 99 APIs under consideration. Chronic ecotoxicity endpoints were only available for 21 compounds so the ecotoxicity values of the others were estimated using the QSAR Toolbox and the ECOSAR software. In terms of data on mammalian safety, data were available on the toxicity of 72 compounds, 87 had an ADI and 88 had a H~T~PC. Experimental bioconcentration factors in fish (BCFfish) were only available for two compounds (diclofenac and naproxen). Experimental organic carbon partition coefficient (Koc) values were only available for 21 pharmaceuticals (Table [1](#Tab1){ref-type="table"}).Table 1Summary of experimental data available for the APIs under considerationParameterNumber of compoundsExcretion profile (Fex)81Log Kow90pKa94Experimental Koc21Experimental endpoint (acute LC(EC) 50)51Experimental endpoint (chronic LC(EC) 50)21Experimental Bioconcentration factor in fish2Acceptable daily intake (ADI)87Mammalian toxicity (LD50) for rat/mouse72Human therapeutic plasma concentration (H~T~PC)88*Fex* fraction of parent ingredients excreted unchanged via human metabolism, *log Kow* octanol-water partitioning coefficient, *pKa* dissociation coefficient, *Koc* organic carbon partition coefficient, *EC50* 50 % effective concentration, *LC50* 50 % lethal concentration, *LD50* median lethal dose for rat/mouse, *BCF* bioconcentration factor in fish, *ADI* acceptable daily intake, *H* ~*T*~ *PC* human therapeutic plasma concentration

RCR lists of APIs in different systems {#Sec12}
--------------------------------------

The top ranked APIs with RCR \>0.1, derived from the different prioritizations for the aquatic environments in the three cities under consideration and at two dilution factors, are presented in Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"} for surface water and Table [4](#Tab4){ref-type="table"} for sediment. The compounds on the top of the prioritization list with an RCR ≥1 according to PECsw and acute ecotoxicological endpoint were amoxicillin, azithromycin, cefalexine, valproic acid, erythromycin, paracetamol and clarithromycin in Mosul and Basrah. In Baghdad, only five compounds had an RCR ≥1 (amoxicillin, clarithromycin, azithromycin, valproic acid and paracetamol). This difference between the cities is due to the absence of wastewater treatment processes in Mosul and Basrah and hence that no removal of APIs by adsorption on sludge will occur in these cities. When chronic effects were considered, at the lower dilution factor, six compounds had RCR values ≥1 for all cities i.e. amoxicillin, clarithromycin, diclofenac, miconazole nitrate and mefenamic acid. At the higher dilution rate, only two compounds (amoxicillin and clarithromycin) had an RCR ≥1 (Table [3](#Tab3){ref-type="table"}). All other pharmaceuticals had a risk score \<0.1 (Table [S3](#MOESM1){ref-type="media"}, Supporting Information).Table 2Top ranked APIs with RCR \>0.1 from each prioritization approach for exposure via surface water at D = 10LocationRCRLow level trophicSubtle effects on fishMammalian predatorHuman (uptake from fishery products)Human (uptake from drinking water)Effect of antibiotics on bacteriaAcute aquaticChronic aquaticFSSPC: H~T~PCPECFISH: PNEC mammalPECFISH: PNEC biota, hhPECSW: PNEC dw, hhPECSW: MICPECSW: MSCPEC SW: PNEC resistance selection(PECSW: acute PNEC aquatic)(PECSW: chronic PNEC aquatic)D10D10D10D10D10D10/D40D10D10D10Baghdad\>10Amoxicillin ClarithromycinAmoxicillin ClarithromycinPhenylephrine Atorvastatin Mebeverine Mefenamic acidPhenylephrinePhenylephrineAmoxicillin Metronidazole1--≤10Azithromycin\
Valproic acid ParacetamolDiclofenac Miconazole nitrate Mefenamic acidMefenamic acid Miconazole nitrateAtorvastatinAmoxicillinAmoxicillin Ceftriaxone Sodium MetronidazoleTrimethoprim Ceftriaxone Sodium Ampicillin Clarithromycin Cefalexine0.1--\<1Cefalexine Ciprofloxacin Miconazole nitrate Mefenamic acid Erythromycin IbuprofenErythromycin Paracetamol Naproxen Azithromycin Mesalazine MebeverineAmitriptyline Metformin Miconazole nitrateValproic acid Diazepam AtorvastatinMefenamic acid Valproic acid Miconazole nitrareCeftriaxone Sodium Metronidazole AmpicillineClarithromycin Trimethoprim Cefalexine AmpicillineCiprofloxacin AzithromycinMosul\>10Amoxicillin AzithromycinAmoxicillin ClarithromycinPhenylephrine Atorvastatin MebeverinePhenylephrinePhenylephrineAmoxicillin Metronidazole1--≤10Ciprofloxacin Valproic acid Erythromycin Paracetamol ClarithromycinCefalexineErythromycin Diclofenac Miconazole nitrate Mefenamic acidAmitriptyline Mefenamic acidAtorvastatinAmoxicillinAmoxicillin Ceftriaxone Sodium MetronidazoleCiprofloxacin Trimethoprim Ceftriaxone Sodium Ampicillin Clarithromycin Cefalexine Erythromycin0.1--\<1Miconazole nitrate Mefenamic acid Ibuprofen Tetracycline Metronidazole TrimethoprimParacetamol Azithromycin Naproxen Mesalazine MebeverineMetformin Miconazole nitrateDiazepam Atorvastatin OctreotideOctreotideTramadolCeftriaxone Sodium Metronidazole Ciprofloxacin Ampicillin TrimethoprimCiprofloxacin Clarithromycin Trimethoprim Cefalexine E ythromycin AmpicillinAzithromycinBasrah\>10Amoxicillin AzithromycinAmoxicillin Clarithromycin ErythromycinPhenylephrine Atorvastatin MebeverinePhenylephrinePhenylephrineAmoxicillin Metronidazole1--≤10Ciprofloxacin Valproic acid Erythromycin Paracetamol Clarithromycin CefalexineDiclofenac Miconazole nitrate Mefenamic acidAmitriptyline Mefenamic acidAtorvastatinAmoxicillinAmoxicillin Ceftriaxone Sodium MetronidazoleCiprofloxacin Trimethoprim Ceftriaxone Sodium Ampicillin Clarithromycin Cefalexine Erythromycin0.1--\<1Miconazole nitrate Mefenamic acid Ibuprofen Tetracycline Metronidazole Trimethoprim AtorvastatinParacetamol Azithromycin Naproxen Mesalazine MebeverineMetformin Miconazole nitrate GlibenclamideDiazepam Atorvastatin Octreotide Miconazole nitrare CaptoprilOctreotide CaptoprilTramadolCeftriaxone Sodium Metronidazole Ciprofloxacin Ampicillin Trimethoprim ErythromycinCiprofloxacin Clarithromycin Trimethoprim Cefalexine Erythromycin AmpicillinAzithromycin*PECsw* predicted environmental concentration in surface water, *FSSPC* fish steady-state plasma concentration, *H* ~*T*~ *PC* human plasma therapeutic concentration, *PECFISH* predicted environmental concentration in fish, *PNEC dw* predicted no-effect concentrations in drinking water, *PNECaquatic/PNECmammal* predicted no-effect concentrations in aquatic and mammalian organisms, *MIC* minimal inhibitory oncentration, *MSC* minimal selective concentration, *PNEC resistance selection* predicted no effect concentrations for antimicrobial resistance, *D* dilution factorTable 3Top ranked APIs with RCR \>0.1 from each prioritization approach for exposure via surface water at D = 40LocationRCRLow level trophicSubtle effects on fishMammalian predatorHuman (uptake from fishery products)Human (uptake from drinking water)Effect of antibiotics on bacteriaAcute aquaticChronic aquaticFSSPC: H~T~PCPECFISH: PNEC mammalPECFISH: PNEC biota, hh(PECSW: PNEC dw, hh)PECSW: MICPECSW: MSCPEC SW: PNEC resistance selection(PECSW: acute PNEC aquatic)(PECSW: chronic PNEC aquatic)D40D40D40D40D40D10/D40D40D40D40Baghdad\>10AmoxicillinAmoxicillinPhenylephrinePhenylephrineAmoxicillin Metronidazole1--≤10Clarithromycin Azithromycin Valproic acidClarithromycinAtorvastatin MebeverinePhenylephrineAmoxicillinTrimethoprim Ceftriaxone Sodium Ampicillin Clarithromycin0.1--\<1Paracetamol Cefalexine Ciprofloxacin Miconazole nitrate Mefenamic acidDiclofenac Miconazole nitrate Mefenamic acid Erythromycin ParacetamolMefenamic acid AmitriptylineMefenamic acid Miconazole nitrateAtorvastatinAmoxicillinCeftriaxone Sodium MetronidazoleCefalexine Ciprofloxacin Azithromycin CiprofloxacinMosul\>10AmoxicillinAmoxicillinPhenylephrinePhenylephrinePhenylephrineAmoxicillin Metronidazole1--≤10Azithromycin Ciprofloxacin Valproic acid ErythromycinClarithromycin ErythromycinAtorvastatin MebeverineAmoxicillinCiprofloxacin Trimethoprim Ceftriaxone Sodium Ampicillin Clarithromycin Cefalexine Erythromycin0.1--\<1Paracetamol Clarithromycin Cefalexine Miconazole nitrate Mefenamic acidDiclofenac Miconazole nitrate Mefenamic acid Paracetamol Azithromycin NaproxenAmitriptyline Mefenamic acidAtorvastatin OctreotideTramadolAmoxicillin Ceftriaxone SodiumCeftriaxone Sodium Metronidazole CiprofloxacinAzithromycinBasrah\>10AmoxicillinAmoxicillinPhenylephrine AtorvastatinPhenylephrine HCLPhenylephrineAmoxicillin1--≤10Azithromycin Ciprofloxacin Valproic acid ErythromycinClarithromycin ErythromycinMebeverineAmoxicillinAmoxicillinM tronidazole Ciprofloxacin Trimethoprim0.1--\<1Paracetamol Clarithromycin Miconazole nitrate Cefalexine Mefenamic acid Tetracycline Ibuprofen DiphenhydramineDiclofenac Miconazole nitrate Mefenamic acid Paracetamol Azithromycin NaproxenAmitriptyline Mefenamic acid MetforminDiazepamAtorvastatin OctreotideTramadolCeftriaxone Sodium MetronidazoleCeftriaxone Sodium Metronidazole CiprofloxacinCeftriaxone Sodium Ampicillin Clarithromycin Cefalexine Erythromycin Azithromycin*PECsw* predicted environmental concentration in surface water, *FSSPC* fish steady-state plasma concentration, *H* ~*T*~ *PC* human plasma therapeutic concentration, *PECFISH* predicted environmental concentration in fish, *PNEC dw* predicted no-effect concentrations in drinking water, *PNECaquatic/PNECmammal* predicted no-effect concentrations in aquatic and mammalian organisms, *MIC* minimal inhibitory oncentration, *MSC* minimal selective concentration, *PNEC resistance selection* predicted no effect concentrations for antimicrobial resistance, *D* dilution factor.Table 4Top ranked APIs with RCR \>0.1 in the three cities (Baghdad, Mosul, Basrah) according to the predicted concentrations in sediment (PECsed) and at 10 and 40 dilution factorsBaghdadMosulBasrahAcute aquatic (PECsed: acute PNECsed)Chronic aquatic (PECsed: chronic PNECsed)Acute aquatic (PECsed: acute PNECsed)Chronic aquatic (PECsed: chronic PNECsed)Acute aquatic (PECsed: acute PNECsed)Chronic aquatic (PECsed: chronic PNECsed)RCRD10D40D10D40D10D40D10D40D10D40D10D40\>10AmoxicillinAmoxicillin Erythromycin Azithromycin CiprofloxacinAmoxicillinAmoxicillin ClarithromycinAmoxicillin Erythromycin Azithromycin CiprofloxacinAmoxicillin ErythromycinAmoxicillin ClarithromycinAmoxicillin1-10Erythromycin Azithromycin Valproic acid Paracetamol CiprofloxacinAmoxicillin Erythromycin Azithromycin Valproic acidAmoxicillin Clarithromycin Diclofenac Miconazole nitrate Mefenamic acidAmoxicillin ClarithromycinValproic acid Paracetamol CefalexinAzithromycin Erythromycin Ciprofloxacin Valproic acidErythromycin Diclofenac Miconazole nitrate Mefenamic acidAmoxicillin Clarithromycin Erythromycin DiclofenacValproic acid Paracetamol ClarithromycinAzithromycin Ciprofloxacin Valproic acidErythromycin Diclofenac Miconazole nitrate Mefenamic acidClarithromycin Erythromycin0.1--\<1Cefalexine Miconazole nitrate Clarithromycin Mefenamic acid Ibuprofen Metronidazole ErythromycinParacetamo Ciprofloxacin Cefalexine Miconazole nitrate Clarithromycin Mefenamic acidParacetamol Naproxen Erythromycin Azithromycin Mesalazine MebeverineDiclofenac Miconazole nitrate Mefenamic acidParacetamolMiconazole nitrate Clarithromycin Mefenamic acid Ibuprofen Tetracycline Metronidazole TrimethoprimParacetamol Cefalexine Miconazole nitrate Clarithromycin Mefenamic acidParacetamol Azithromycin Naproxen Mesalazine MebeverineMiconazole nitrate Mefenamic acid Paracetamol Azithromycin NaproxenCefalexine Miconazole nitrate Mefenamic acid Ibuprofen MetronidazoleParacetamol Clarithromycin Cefalexine Miconazole nitrate Mefenamic acidParacetamol Naproxen Azithromycin Mesalazine MebeverineDiclofenac Miconazole nitrate Mefenamic acid ParacetamolThe PECsed and PNECsed were calculated with the equilibrium partitioning method from the PECsw and PNECsw, respectively*PECsed* predicted environmental concentration in sediment, *PNECsed* predicted no effect concentrations in sediment, *D* dilution factor

When the potential impact of subtle pharmacological effects were considered by comparing the human therapeutic concentration in plasma to estimated levels in fish plasma, using a dilution factor of 10, phenylephrine, atorvastatin and mebeverine showed RCR values \>1 in all three cities. Additionally, amitriptyline and mefenamic acid had an RCR ≥1 In Mosul and Basrah. Using the higher dilution factor, only phenylephrine showed RCR \>1 in Baghdad and Mosul whereas phenylephrine and atorvastatin exceeded an RCR of 1 in Basrah (Table [3](#Tab3){ref-type="table"}).

Assessment of human exposure from consumption of fish products showed that phenylephrine and atorvastatin had an RCR \>1 in all cities when a DF of 10 was used and only phenylephrine (RCR \>1) when the DF of 40 was used. For human exposure via drinking water, tramadol HCL was the highest ranked compound (with an RCR between 0.1 and 1 while for the rest of pharmaceuticals the RCR was below 0.1.

The predicted concentrations for amoxicillin in all cities when DF = 10 was used were close to the MICs, and the RCRs were between 1 to 10, suggesting that concentration could be high enough to inhibit growth of or kill bacteria. Amoxicillin and metronidazole were on the top list of antibiotics identified as a risk for selection for bacterial resistance (RCR \>10), with a further seven APIs having RCR values between 1 and 10 (Tables [2](#Tab2){ref-type="table"} and [3](#Tab3){ref-type="table"}).

The highest ranked APIs based on acute effect in sediment organisms were amoxicillin, erythromycin, azithromycin, ciprofloxacin, valproic acid and paracetamol in all cities with RCR \>1 (Table [4](#Tab4){ref-type="table"}). Ciprofloxacin was dropped off the top priority list when a DF of 40 was applied in Mosul and Basrah and also paracetamol in Baghdad. The highest ranked compounds based on chronic endpoints were amoxicillin, clarithromycin, diclofenac, miconazole nitrate and mefenamic acid at DF = 10 and only amoxicillin showed RCR \>10 in Basrah at DF = 40.

In soil, theophylline was ranked highest priority based on the effect on lower trophic level organisms (earthworm). Based on the potential for secondary poisoning in the aquatic environment (i.e. risk to mammalian predators), only phenylephrine had an RCR \>1 for all the city scenarios. For secondary poisoning in the terrestrial environments (i.e. earthworm-eating birds and mammals), the highest ranked compound was atropine with an RCR between 0.1 and 1 (Table [5](#Tab5){ref-type="table"}).Table 5Top 20 compounds from each prioritization approach considered (Baghdad only), according to the predicted concentrations in soil (PECsoil)RCRLow level trophicHigher trophic levels\
Mammalian predatorPECsoil: PNECwormPECearthworm: PNECmammalPECearthworm: ADI\>101--101 Theophylline\
2 Omeprazole\
3 Olanzapine0.1--\<14 Fluoxetine\
5 Atropine sulphate\
6 Guaifenesin\
7 Ciprofloxacin\
8 Phenylephrine\
9 Metoprolol\
10 Mefenamic acid\
11 Octreotide\
12 Procyclidine\
13 Valproic acid\
14 Dextromethorphan Hydrobromide\
15 Pethidine1 Atropine sulphate\<0.116 Diphenhydramine\
17 Sitagliptin\
18 Flutamide\
19 Trifluoperazine\
20 Fluovastatin2 Procyclidine\
3 Olanzapine\
4 Diazepam\
5 Metoclopramide\
6 Octreotide\
7 Omeprazole\
8 Sitagliptin\
9 Guaifenesin\
10 Dextromethorphan Hydrobromide\
11 Diphenhydramine\
12 Metoprolol\
13 Ranitidine\
14 Chlorphenamine Maleate\
15 Ciprofloxacin\
16 Theophylline\
17 Pseudoephedrine\
18 Pethidine\
19 Neostigmine\
20 Escitalopram oxalate1 Atropine sulphate\
2 Olanzapine\
3 Omeprazole\
4 Octreotide\
5 Procyclidine\
6 Metoprolol\
7 Escitalopram oxalate\
8 Sitagliptin\
9 Thyroxine sodium\
10 Ranitidine\
11 Guaifenesin\
12 Dextromethorphan Hydrobromide\
13 Trifluoperazine\
14 Ketotifen\
15 Letrozole\
16 Midazolam\
17 Metoclopramide\
18 Infliximab\
19 Pseudoephedrine\
20 Bromhexine*PECsoil, PECearthworm* predicted environmental concentrations in in soil and earthworm, *ADI* acceptable daily intake, *PNECmammal, PNECworm* predicted no-effect concentrations in mammals and in worm

Comparison of ranking outcomes {#Sec13}
------------------------------

Generally, the outcome of the risk-based prioritization showed that the majority of the top ranked pharmaceuticals were antibiotics. Based on all risk comparisons, a final list of 23 compounds (amoxicillin, amitriptyline, ampicillin, atorvastatin, azithromycin, cefalexine, ceftriaxone sodium, ciprofloxacin, clarithromycin, diclofenac, erythromycin, ibuprofen, valproic acid, mebeverine, mefenamic acid, metronidazole, miconazole nitrate, olanzapine, omeprazole paracetamol, phenylephrine, theophylline, trimethoprim) which had an RCR \>1 for at least one endpoint or compartment was generated. Interestingly, the results of the current prioritization approach agreed with previously published prioritization studies from other countries. Amoxicillin, the compound with the highest score in this study, was also ranked the top veterinary medicine with high hazard to aquatic organisms in the UK and Korea (Boxall et al. [@CR13]; Kim et al. [@CR47]). Clarithromycin and azithromycin where found alongside amoxicillin on the top priority list in France (Besse and Garric [@CR9]). Paracetamol, amoxicillin and azithromycin were ranked as highly prescribed pharmaceuticals of concern in the USA whereas ciprofloxacin was identified as posing a risk toward aquatic organisms and humans (Dong et al. [@CR19]). Paracetamol, mefenamic acid, amoxicillin, ciprofloxacin, erythromycin and valproic acid were prioritized as highest environmental risk in Switzerland (Perazzolo et al. [@CR63]). A prioritization study performed by Roos et al. ([@CR65]) showed amitriptyline, paracetamol, diclofenac and valproic acid to be the highest ranked compounds in one or more comparison studies in Sweden while no antibiotics from this study were found in the ranking lists. Paracetamol ranked the 2nd in terms of usage volume in Sweden while in Iraq it was found to be 1st on the prioritization list. Diclofenac showed a risk score of 0.013 which is equal to the one reported in the UK by Ashton et al. ([@CR5]). On the other hand, this compound showed a higher risk score (1--10) in Iraq when chronic ecotoxicological endpoints were used. A recent risk-based prioritization study in the UK has shown most of the antibiotics in our list (amoxicillin, azithromycin, ciprofloxacin, clarithromycin and atorvastatin) to have risk scores greater than 1 in one or more of the risk comparisons proposed (Guo et al. [@CR35]). Amitriptyline was ranked as high priority compound when the potential impact of subtle pharmacological effects was considered by comparing the H~T~PC to estimated levels in fish in the same study. Miconazole was ranked as one of the priority substances used as herd treatment that is moderately used and metabolized (Boxall et al. [@CR13]). It was also found on the top ranking list of pharmaceuticals according to the fish plasma model (Roos et al. [@CR65]). Theophylline showed low risk score in aquatic system, and this agrees with a ranking score of 0.015 in surface water reported by Huschek et al. ([@CR41]); while in this study the RCR of theophylline toward terrestrial lower trophic levels was \>1 followed by omeprazole and olanzapine. Omeprazole was ranked 19th and 22nd in terms of number of prescribed pharmaceuticals in the prioritization studies in the USA and Sweden (Dong et al. [@CR19]; Roos et al. [@CR65]). No previous prioritization study has ranked phenylephrine as a compound of concern. To our knowledge and after reviewing the literature, antibiotics have not been previously prioritized in surface water in terms of their impact on bacterial community or the susceptibility to pose bacterial resistance.

Pharmaceuticals of concern on the top of priority lists {#Sec14}
-------------------------------------------------------

Antibiotics are often ranked as the highest priority compounds in risk characterization exercises. Recently, the awareness of the risks of antibiotics in the environment has been raised. For example, the European Environmental Quality Directive has added four antibiotics to the watch list of the Water Framework Directive (Carvalho et al. [@CR15]). All of the added antibiotics (azithromycin, erythromycin, ciprofloxacin and clarithromycin) are ranked as high risk compounds in our priority list. Antibiotics are structurally diverse and do not share a common mode of action (Sanderson et al. [@CR67]), and very low concentrations of antibiotics can be considered extremely harmful to organisms and high concentrations of antibiotics in sediment inhibit the growth of bacteria (Kümmerer [@CR51], [@CR52]).

The occurrence and diverse effects of some of the highly ranked APIs have been reported. Although ciprofloxacin, a fluoroquinolone antibiotic, is highly removed in WWTPs, a concentration of 3.8 μg L^−1^ was detected in wastewater effluent in Australia (Watkinson et al. [@CR75]) and much higher concentrations of 6.5 and 14.0 mg L^−1^ from two lakes and pharmaceutical production effluent in India, respectively (Fick et al. [@CR27]). Ciprofloxacin showed luminescence inhibition to *Vibrio fisheri* at 5 mg L^−1^ of 30-min EC50 (Hernando et al. [@CR37]) and shows high toxicity toward cyanobacteria (*Microcystis aeruginosa*) with an EC50 of 0.005 mg L^−1^ with growth inhibition as the endpoint (Halling-Sorensen [@CR36]). In a recent study, ciprofloxacin exposure resulted in growth inhibition of algae (*Pseudokirchneriella subcapitata*) at a 96-h EC50 of 4.83 mg L^−1^ (Martins et al. [@CR55]). Erythromycin is frequently detected in water around the world with concentrations between 0.13 and 0.89 μg L^−1^ (Meinertz et al. [@CR56]; Hernando et al. [@CR38]). It was found to be toxic to algae using chronic tests with a reported EC50 between 0.01 and 0.1 mg L^−1^ while ecotoxicological results showed that acute toxicity was in the range of 10--30 mg L^−1^ for algae, daphnia and bacteria (Isidori et al. [@CR42]). Clarithromycin, a derivative of erythromycin, was detected in concentrations between 0.01 and 0.54 μg L^−1^ in different countries and has been shown to inhibit the growth of algae and cyanobacteria with EC50 values of 0.0371 and 0.0121 mg L^−1^, respectively (Baumann et al. [@CR6]). The PECsw of amoxicillin, a β-lactam antibiotic, in Iraqi cities was very high and ranged from 0.6 to 24.0 μg L^−1^. This concentration is extremely high in comparison to levels \<0.001 μg L^−1^ detected in other countries such as in Italy (Castiglioni et al. [@CR16]). It shows high toxicity to blue-green algae (cyanobacteria) with a reported 96-h EC50 of 0.00222 mg L^−1^ (Fass.se) and is known to cause hepatocyte cytotoxicity as side effect to rainbow trout with a 24-h EC50 \>182.7 mg L^−1^ (Laville et al. [@CR53]).

In addition to direct toxicological risks, the occurrence of antibiotics raises concerns in terms of the promotion of antibiotic resistance in bacteria in environment, which could subsequently make antibiotics ineffective in terms of treatment for both humans and animals since aquatic ecosystems are a recognized reservoir for antibiotic-resistant bacteria (Santos et al. [@CR68]; Kostich et al. [@CR50]; Ågerstrand et al. [@CR3]). Interestingly, the occurrence of antibiotic resistance in the environment is not on the main list of priorities that should be addressed by guidelines for the environmental risk assessment of medicinal products for both human and veterinary use in the European Union \[European Medicines Agency (EMEA) [@CR24]; [@CR25]\]. Studies from different parts of the world have highlighted the fact that resistant strains of bacteria occur in the environment. For example, in Slovakia, the occurrence of resistance to different antibiotics (erythromycin, clarithromycin, azithromycin, ciprofloxacin, trimethoprim) in coliforms and streptococci from WWTPs sludge was studied (Birošová et al. [@CR10]). In Canada, isolated *Escherichia coli* retrieved from different sites and aquatic ecosystem compartments (biofilms, sediment and water) showed high frequency of resistance to ampicillin and ciprofloxacin (Maal-Bared et al. [@CR54]). In Brazil, three strains of *Salmonella* from water samples of a shrimp farm exhibited multiresistance to ampicillin, tetracycline, oxytetracycline and nitrofurantoin (Carvalho et al. [@CR17]). Recently, a study of tetracyclines, sulfonamides and (fluoro)quinolones in sediment and water samples in Guangdong, China, indicated that fish ponds are reservoirs of antimicrobial resistance genes and the presence of potential resistant and pathogen-associated taxonomic groups in fish ponds might imply the potential risk to human health (Xiong et al. [@CR76]).

Two non-steroidal anti-inflammatory drugs (NSAIDs) were identified as high priority APIs i.e. diclofenac and mefenamic acid. In 2013, the European Directive identified diclofenac, alongside two synthetic hormones, as pollutants that should be included in the Water Framework Directive Watch List (Carvalho et al. [@CR15]). van den Brandhof and Montforts ([@CR74]) reported the effect of diclofenac on growth retardation in zebrafish after exposure to concentrations \>1.5 mg L^−1^. Hoeger et al. ([@CR40]) and Schwaiger et al. ([@CR69]) documented that diclofenac has the potential to cause histopathological damage to tissues (kidney) in fish at concentrations close to those regularly found in surface waters. Mefenamic acid showed a maximum PECsw (1.2 μg L^−1^) which is higher than the reported levels (0.20-0.34 μg L^−1^) in the UK by Roberts and Thomas ([@CR64]). Ecotoxicological effect of mefenamic acid in chronic toxicity tests to *Daphnia magna* and *Moina macrocopa* showed significant changes in reproduction (number of young per adult) after the exposure to 1.0 and 0.25 mg L^−1^ of mefenamic acid, respectively (Jung Collard et al. [@CR44]). The top used compound in Iraq is paracetamol. In our study, the maximum PECsw for paracetamol in Iraqi cities was 23.99 μg L^−1^ in Basrah which is two times higher than the concentration obtained from a study by Jones et al. ([@CR43]) who found the maximum PEC in English rivers to be 11.96 μg L^−1^ and more than two orders of magnitude higher than the concentration of 0.11 μg L^−1^ which was detected in 24 % of the rivers in the USA (Kolpin et al. [@CR48]). In terms of ecotoxicological effect, Galus et al. ([@CR31]) found that embryonic mortality of zebrafish was raised after exposure to paracetamol at the level of ≥0.5 μg L^−1^. Very limited studies have been performed on ecotoxicity of valproic acid toward environmental organisms. Herrmann ([@CR39]) carried out a prescreen test to investigate the possible hazard posed to humans using zebra fish exposure to valproic acid and revealed that exposure caused retardation and interruption of development. The cholesterol-lowering agent atorvastatin was reported to affect lemna (*Lemna gibba*) by decreasing pigment content at EC50 0.17 mg L^−1^ (Brain et al. [@CR14]). It was also found to inhibit growth of *Hyalella azteca* with LC50 values ranging from 1.30 to 3.56 mg L^−1^ and *Chironomus tentans* with LC50 values ranging from 3.94 to 16.42 mg L^−1^ (Dussault et al. [@CR21]). Amitriptyline was identified as a high priority list due to its potential to elicit subtle effect in fish in the current study. It has previously been reported to pose a risk to surface waters and show toxicity to fish and daphnia, EC50 = 0.78 mg L^−1^ (Kasprzyk-Hordern [@CR45]). In lower trophics, amitriptyline was reported to inhibit the growth of a macrophyte *Lemna minor* with a 7-day EC50 of 1.69 mg L^−1^ (Ågerstrand and Rudén [@CR2]).

Ibuprofen is predicted to occur in Iraqi surface water at concentrations of 0.13--0.8 μg L^−1^ and sediment at concentrations of 3.0--20 μg Kg^−1^. The log Kow of 3.73 and low solubility suggest the low mobility of ibuprofen in water and affinity to adsorb to sediment (Bouissou-Schurtz et al. [@CR11]). Ibuprofen was detected at a concentration of 1.3 μg L^−1^ in surface water in Switzerland (Tixier et al. [@CR71]) and 0.15--3.96 μg L^−1^ in the influent and effluent wastewater in Sweden (Bendz et al. [@CR7]). It was found that exposure to chronic low levels of ibuprofen alters the pattern of reproduction of Japanese medaka, *Oryzias latipes*, and may produce sex-specific responses in teleosts (Flippin et al. [@CR29]). Ibuprofen at a concentration slightly higher than 0.2 μg L^−1^ is able to significantly increase both genetic and cellular damage in freshwater bivalve *Dreissena polymorpha* (Parolini et al. [@CR62]).

Limitation of the method {#Sec15}
========================

Knowledge about usage data is essential to establish a priority list of pharmaceuticals of most concern. In Iraq, it was difficult to obtain the consumption amount of all pharmaceuticals from the ministry of health list due to absence of a governmental statistical data and it is sometimes considered confidential. Moreover, it was not possible to quantify the usage data of over-the-counter (OTC) pharmaceuticals. Therefore, an accurate quantification approach of OTC usage should be a future priority. The project did not consider veterinary pharmaceuticals, but this use pattern could also be an important contributor to the environment, particularly for antibiotic compounds.

Another restraint which increases the uncertainty is the limited availability of ecotoxicological endpoints and the high dependence on the prediction of effects and properties. For example, the practice of using ECOSAR to extrapolate ecotoxicity data may not be appropriate since this software was developed to assess toxicity of compounds other than pharmaceuticals. Physico-chemical properties were also limited; for instance, Koc which was used to estimate adsorption during wastewater treatment was calculated by an empirical estimation model (Franco and Trapp [@CR30]) due to absence of experimental values for all the pharmaceuticals on the list. Moreover, bioconcentration factors for worm (BCFworm) was predicted according to the TGD 2003 to allow the secondary poisoning assessment of pharmaceuticals in the terrestrial compartment due to limited availability of experimental data. This estimation is usually higher than the experimentally obtained BCF values (TGD [@CR23]). Therefore, an improvement in the accuracy of BCFworm estimation in soil warrants further consideration.

Conclusion {#Sec16}
==========

An approach has been developed for prioritizing substances that may pose a risk to the aquatic and terrestrial systems in Iraq. Pharmaceutical usage data has been used together with information on the physico-chemical properties, patient metabolism and wastewater treatment removal in this practice to predict API concentrations. The ranking has been performed by comparing these concentrations to a range of experimental and estimated ecotoxicological endpoints including non-standard endpoints such as the potential for subtle pharmacological effects, secondary poisoning and the impact on human via consuming fishery products and drinking water. Dilution factor was found to play an important role to reduce the risk suspected to be posed toward environmental organisms by pharmaceuticals, and results of this study showed that the release of pharmaceuticals to the aquatic environment represents a significant environmental threat, especially when DF is low.

Twenty-three APIs including antibiotics, analgesics, antiepileptics, anti-hypercholesterolemia and anti-asthma have been identified as high priority substances. The study indicates that antibiotics are the pharmaceutical class of most concern with annual consumption of these molecules in Iraq up to 420 t year^−1^. Risks of pharmaceutical compounds in drinking water to human health are low with the exception of tramadol when no WWTP connectivity exists. Large numbers of pharmaceuticals considered in this study could be removed during wastewater treatment, and their risk towards environment will be highly reduced when a proper removal mechanism is used, but in our study case, the removal by this method is neglected due to the absence or inefficient operation of WWTPs in Iraq. Further evaluation is recommended to assess whether these compounds could indeed pose a risk to the environment as individuals or in a mixture since a broad range of different substances is used simultaneously in humans in any given area.
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